Vaccines against avian influenza--a race against time
- PMID: 16571885
- DOI: 10.1056/NEJMe068047
Vaccines against avian influenza--a race against time
Comment in
-
An inactivated subvirion influenza A (H5N1) vaccine.N Engl J Med. 2006 Jun 22;354(25):2724-5; author reply 2724-5. N Engl J Med. 2006. PMID: 16795150 No abstract available.
Comment on
-
Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.N Engl J Med. 2006 Mar 30;354(13):1343-51. doi: 10.1056/NEJMoa055778. N Engl J Med. 2006. PMID: 16571878 Clinical Trial.
Similar articles
-
An inactivated subvirion influenza A (H5N1) vaccine.N Engl J Med. 2006 Jun 22;354(25):2724-5; author reply 2724-5. doi: 10.1056/NEJMc061152. N Engl J Med. 2006. PMID: 16790710 No abstract available.
-
Immunogenicity, safety, and cross-reactivity of an inactivated, adjuvanted, prototype pandemic influenza (H5N1) vaccine: a phase II, double-blind, randomized trial.Clin Infect Dis. 2009 Apr 15;48(8):1087-95. doi: 10.1086/597401. Clin Infect Dis. 2009. PMID: 19281330 Clinical Trial.
-
Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model.Vaccine. 2007 May 4;25(18):3554-60. doi: 10.1016/j.vaccine.2007.01.083. Epub 2007 Jan 30. Vaccine. 2007. PMID: 17293015
-
Vaccines in development against avian influenza.Minerva Med. 2007 Apr;98(2):145-53. Minerva Med. 2007. PMID: 17519856 Review.
-
Strategies for developing vaccines against H5N1 influenza A viruses.Trends Mol Med. 2006 Nov;12(11):506-14. doi: 10.1016/j.molmed.2006.09.003. Epub 2006 Sep 29. Trends Mol Med. 2006. PMID: 17011235 Review.
Cited by
-
Zoonoses, One Health and complexity: wicked problems and constructive conflict.Philos Trans R Soc Lond B Biol Sci. 2017 Jul 19;372(1725):20160171. doi: 10.1098/rstb.2016.0171. Philos Trans R Soc Lond B Biol Sci. 2017. PMID: 28584179 Free PMC article. Review.
-
Hybrid inorganic-organic capsules for efficient intracellular delivery of novel siRNAs against influenza A (H1N1) virus infection.Sci Rep. 2017 Mar 7;7(1):102. doi: 10.1038/s41598-017-00200-0. Sci Rep. 2017. PMID: 28273907 Free PMC article.
-
Repeated Low-Dose Influenza Virus Infection Causes Severe Disease in Mice: a Model for Vaccine Evaluation.J Virol. 2015 Aug;89(15):7841-51. doi: 10.1128/JVI.00976-15. Epub 2015 May 20. J Virol. 2015. PMID: 25995265 Free PMC article.
-
The spatial resolution of epidemic peaks.PLoS Comput Biol. 2014 Apr 10;10(4):e1003561. doi: 10.1371/journal.pcbi.1003561. eCollection 2014 Apr. PLoS Comput Biol. 2014. PMID: 24722420 Free PMC article.
-
Protection from avian influenza H5N1 virus infection with antibody-impregnated filters.Virol J. 2011 Feb 8;8:54. doi: 10.1186/1743-422X-8-54. Virol J. 2011. PMID: 21303494 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical